Interstitial Lung Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ?Any gender, age = 18; ?Meet the diagnostic criteria for interstitial lung disease, including acute exacerbation and stable phase, in accordance with the 2002 American Thoracic Society (ATS) and European Respiratory Society (ERS) Expert Group Consensus, the 2018 Chinese Expert Consensus on the Diagnosis and Treatment of Connective Tissue Disease-Related Interstitial Lung Disease, and the 2019 Chinese Expert Consensus on the Diagnosis and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis; ?Patients volunteered to participate in this study and signed an informed consent form.
Exclusion criteria
Exclusion criteria: ?Persons suffering from severe cardiovascular, hematologic, hepatic, renal and other organ dysfunctions; ?Persons with mental illnesses who are unable to cooperate with the research study; ?Persons with acute and chronic infectious diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine syndromes;clinical characteristics;Lung function;Chest CT; | — |
Secondary
| Measure | Time frame |
|---|---|
| The Dampness Syndrome Scale of Chinese Medicine;St. George's respiratory questionnaire;Health Survey Summary Form (SF-36);Functional Status Assessment (HAQ);Improved UK Improved UK MRC Dyspnea Scale (mMRC);Borg rating scale;VAS visual simulation score;Generalized Anxiety Scale (GAD-7);Self-rating Tool Scale for Depression (PHQ-9);Self-immunity rheumatism index;Prognostic index of fibrosis;Tumor index;Kinase index;Inflammatory index;Blood gas analysis;electromyogram; | — |
Countries
China
Contacts
Guangdong Provincial Hospital of Chinese Medicine